Another possible facet of the observed pathophysiology in critical cases of COVID-19 is a decline in nitric oxide (NO) and combined with the effect of excessive ROS on the structure and function of hemoglobin (Hb) could impact pulmonary and peripheral circulation, possibly eventually leading to critical or fatal hypoxia (26). This evidence concerns the gene GSTM1 and COVID-19.